- Home
- GGR vs ACHV Comparison
GGR vs ACHV Comparison
Compare GGR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGR
- ACHV
- Stock Information
- Founded
- GGR 2011
- ACHV N/A
- Country
- GGR Taiwan
- ACHV Canada
- Employees
- GGR N/A
- ACHV N/A
- Industry
- GGR Auto Manufacturing
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GGR Consumer Discretionary
- ACHV Health Care
- Exchange
- GGR Nasdaq
- ACHV Nasdaq
- Market Cap
- GGR 150.6M
- ACHV 149.6M
- IPO Year
- GGR N/A
- ACHV N/A
- Fundamental
- Price
- GGR $0.48
- ACHV $4.33
- Analyst Decision
- GGR Hold
- ACHV Strong Buy
- Analyst Count
- GGR 3
- ACHV 5
- Target Price
- GGR $1.35
- ACHV $14.80
- AVG Volume (30 Days)
- GGR 1.1M
- ACHV 116.0K
- Earning Date
- GGR 11-14-2024
- ACHV 11-07-2024
- Dividend Yield
- GGR N/A
- ACHV N/A
- EPS Growth
- GGR N/A
- ACHV N/A
- EPS
- GGR N/A
- ACHV N/A
- Revenue
- GGR $329,041,000.00
- ACHV N/A
- Revenue This Year
- GGR N/A
- ACHV N/A
- Revenue Next Year
- GGR $15.28
- ACHV N/A
- P/E Ratio
- GGR N/A
- ACHV N/A
- Revenue Growth
- GGR N/A
- ACHV N/A
- 52 Week Low
- GGR $0.40
- ACHV $3.03
- 52 Week High
- GGR $2.71
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- GGR 45.19
- ACHV 40.62
- Support Level
- GGR $0.46
- ACHV $4.12
- Resistance Level
- GGR $0.49
- ACHV $4.46
- Average True Range (ATR)
- GGR 0.04
- ACHV 0.24
- MACD
- GGR 0.01
- ACHV -0.05
- Stochastic Oscillator
- GGR 57.79
- ACHV 17.65
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.